Pathway Labs EchoNext

Read the original at TIME ↗
Cite

Sweeney, E. (2026, October 15). Pathway Labs EchoNext. TIME. https://time.com/collection/best-inventions/2026/pathway-labs-echonext/

Dated from the outlet's own feed. Check the original for its byline.

TIME · collected 2026-10-19 · by Erica Sweeney

Quick Summary

Dr. Pierre Elias, founder of PathWay Labs and a professor at Columbia University, has developed an artificial intelligence tool called EchoNext. This tool analyzes routine electrocardiogram data to identify patients who need further ultrasounds for diagnosing structural heart issues. A 2025 study indicated that EchoNext outperformed cardiologists in identifying such problems. The FDA cleared the tool in June, and it is set to be implemented this year across major health systems and through the AI medical platform OpenEvidence.
Written locally by qwen2.5:14b on 2026-10-19, using this article's own text rather than the other coverage of the same event (that is the story summary below).

AI analysis runs on qwen2.5:14b, locally

Story summary

Dr. Pierre Elias, a medical director for AI at NewYork-Presbyterian and assistant professor of medicine and biomedical informatics at Columbia University, has developed EchoNext, an artificial intelligence tool that analyzes data from routine electrocardiograms to identify patients who need additional ultrasounds for diagnosing heart defects or abnormalities. A 2025 study demonstrated that EchoNext identified structural heart problems more accurately than cardiologists. The FDA granted clearance to EchoNext in June, and it will be available this year in multiple major health systems as well as through the AI medical platform OpenEvidence. Structural heart disease affects millions of people globally but often goes undetected until it progresses due to a lack of affordable routine screening options.

Written for “Pathway Labs EchoNext” on 2026-10-19, grounded in this article and the 0 other(s) covering the same event.

Story

📰 Pathway Labs EchoNext
Health · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
4
sentences that state something as happening or true
Uncertain
0%
0 of 4 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
59/100
TIME's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-19 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

TIME · 641 article(s) · 2 correction(s) detected
Running correction rate · 2 correction(s)

Who wrote this

Erica Sweeney
3 article(s) here · 1 carrying a prediction
🔮 Elias says EchoNext will be available in multiple major health systems this year, and will also be available for clinicians via the AI medical platform OpenEvidence.
2026-10-19 · assertive framing · Pathway Labs EchoNext
🔮 “Someone may notice that a shoe that fit well when they were younger now feels too tight, even though their actual foot bones have not continued to grow.”
2026-09-18 · assertive framing · Your Shoe Size Can Change as You Age. Here's Why
🔮 Applying serums or creams with retinol—a vitamin A-derivative known for its anti-aging and acne-fighting properties—may be a mainstay in your skin-care routine.
Also by Erica Sweeney
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Columbia University EchoNext FDA NewYork-Presbyterian PathWay Labs

Subjects

Columbia University ORG · 1× Elias PERSON · 1× FDA ORG · 1× NewYork-Presbyterian ORG · 1× PathWay Labs ORG · 1× Pierre Elias PERSON · 1×

Narrative

So Dr. Pierre Elias, medical director for AI at NewYork-Presbyterian, assistant professor of medicine and biomedical informatics at Columbia University, and now founder and CEO of PathWay Labs, worked with his team to develop EchoNext, an AI tool that analyzes data from routine electrocardiograms to identify patients who need additional ultrasounds to diagnose heart defects or abnormalities.
framing: assertive · carried by 1 article(s) · first seen 2026-10-19
🔮 Elias says EchoNext will be available in multiple major health systems this year, and will also be available for clinicians via the AI medical platform OpenEvidence.
2026-10-19 · TIME
Pathway Labs EchoNext · assertive framing

Claims (4 extracted, 0 hedged)

Structural heart disease affects millions of people worldwide, yet it often goes undetected until it progresses because there’s no affordable routine screening. asserted
it → affect → people
So Dr. Pierre Elias, medical director for AI at NewYork-Presbyterian, assistant professor of medicine and biomedical informatics at Columbia University, and now founder and CEO of PathWay Labs, worked with his team to develop EchoNext, an AI tool that analyzes data from routine electrocardiograms to identify patients who need additional ultrasounds to diagnose heart defects or abnormalities. asserted
who → work → defects
A 2025 study showed that EchoNext identified structural heart problems more accurately than cardiologists, and the tool received FDA clearance in June. asserted
tool → show → June
Elias says EchoNext will be available in multiple major health systems this year, and will also be available for clinicians via the AI medical platform OpenEvidence. asserted
EchoNext → say → platform
💬Give feedback
🕘History 🎫Support